treatment

Early data from a clinical study suggest that an off-label cancer drug provided clinical benefit to a small group of patients with severe COVID-19.The cancer drug acalabrutinib, which blocks the Bruton tyrosine kinase (BTK) protein and is approved to treat some blood cancers, was associated with reduced respiratory distress and a reduction in the overactive…

By Clare Wilson Ventilators have been seen as a crucial tool for treating severe cases of covid-19, but they may not always be neededBuda Mendes/Getty Images When the coronavirus pandemic began, the UK scrambled to get more ventilators for intensive care. But now some doctors are trying to keep people off ventilators as they believe…

Our apologies. An error occurred while setting your user cookie. Please set your browser to accept cookies to continue. NEJM.org uses cookies to improve performance by remembering your session ID when you navigate from page to page. This cookie stores just a session ID; no other information is captured. Accepting the NEJM cookie is necessary…

It appears that you are trying to access our website from a location in the European Union, which enforces the General Data Protection Regulation (GDPR). Unfortunately, because of this regulation we cannot provide access at this time. We appreciate your understanding.

guidelines were released, Dr. Fauci said there were many clinical trials underway. “Right now, it is premature to say if something is going to be a home run or not,” he said. “Right now there are no early indications of a home run anywhere. There’s nothing that has been dramatic at all.”Clinical trials are monitored…